1. Home
  2. EPRT vs GKOS Comparison

EPRT vs GKOS Comparison

Compare EPRT & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EPRT
  • GKOS
  • Stock Information
  • Founded
  • EPRT 2016
  • GKOS 1998
  • Country
  • EPRT United States
  • GKOS United States
  • Employees
  • EPRT N/A
  • GKOS N/A
  • Industry
  • EPRT Real Estate Investment Trusts
  • GKOS Medical/Dental Instruments
  • Sector
  • EPRT Real Estate
  • GKOS Health Care
  • Exchange
  • EPRT Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • EPRT 6.2B
  • GKOS 5.8B
  • IPO Year
  • EPRT 2018
  • GKOS 2015
  • Fundamental
  • Price
  • EPRT $30.80
  • GKOS $94.05
  • Analyst Decision
  • EPRT Buy
  • GKOS Strong Buy
  • Analyst Count
  • EPRT 10
  • GKOS 12
  • Target Price
  • EPRT $35.38
  • GKOS $131.17
  • AVG Volume (30 Days)
  • EPRT 1.2M
  • GKOS 687.1K
  • Earning Date
  • EPRT 10-22-2025
  • GKOS 11-03-2025
  • Dividend Yield
  • EPRT 3.89%
  • GKOS N/A
  • EPS Growth
  • EPRT 1.76
  • GKOS N/A
  • EPS
  • EPRT 1.19
  • GKOS N/A
  • Revenue
  • EPRT $503,256,000.00
  • GKOS $432,953,000.00
  • Revenue This Year
  • EPRT $22.66
  • GKOS $28.79
  • Revenue Next Year
  • EPRT $16.70
  • GKOS $25.65
  • P/E Ratio
  • EPRT $25.93
  • GKOS N/A
  • Revenue Growth
  • EPRT 25.14
  • GKOS 26.70
  • 52 Week Low
  • EPRT $27.44
  • GKOS $77.10
  • 52 Week High
  • EPRT $34.88
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • EPRT 48.67
  • GKOS 52.32
  • Support Level
  • EPRT $30.35
  • GKOS $89.83
  • Resistance Level
  • EPRT $31.11
  • GKOS $97.00
  • Average True Range (ATR)
  • EPRT 0.45
  • GKOS 2.65
  • MACD
  • EPRT 0.01
  • GKOS 0.36
  • Stochastic Oscillator
  • EPRT 37.41
  • GKOS 66.44

About EPRT Essential Properties Realty Trust Inc.

Essential Properties Realty Trust Inc is a real estate investment trust. It is an internally managed real estate company acquires, owns and manages single-tenant properties that are net leased on a long-term basis to middle-market companies operating service-oriented or experience-based businesses. The Company generally invests in and leases freestanding, single-tenant commercial real estate facilities where a tenant services its customers and conducts activities that are essential to the generation of the tenant's sales and profits.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: